Skip to content

Clarity Pharmaceuticals – Radiopharmaceutical Therapies and Imaging

Clarity Pharmaceuticals is a personalised medicine company focused on the treatment of serious disease. The company is a leader in innovative radiopharmaceuticals, developing targeted therapies for the treatment of cancer and other serious diseases in adults and children.

Home
Company
Pipeline
Technology
News
Investor Centre
LinkedIn
Twitter

Home
Company
Pipeline
Technology
News
Investor Centre
LinkedIn
Twitter

Reports and Presentations

Corporate Governance
Financial reports
ASX releases
Shareholder meetings
Analyst Coverage
Shareholder updates
Share Registry

Presentations

Presentation Thumbnail

Presentation Thumbnail

Presentation Thumbnail3

E&P Presentation thumbnail2

Presentation Thumbnail

Presentation March 2023

Presentation Thumbnail

Annual Reports

AR Thumbnail

Artboard 1

Half-Yearly Reports

HY thumbnail website

website

Quarterly Reports

Quarterly thumbnail

23-10-31 Qly Thumbnail

Website Thumbnail

23-04-28 Qly Thumbnail

23-01-31 Qly Thumbnail

Corporate Governance Statement

4G cover thumbnail

Corpotate governance statement 22

ESG Report

Thumbnail

ESG thumbnail small

Prospectus

Prospectus Thumbnail

Newsletter

Sign up to receive Clarity's most recent news and updates

4 Cornwallis Street,
National Innovation Centre,
Eveleigh 2015 NSW
+61 (0)2 9209 4037

Board of Directors

Scientific Advisors

About SAR-Technology

Copper Isotopes

Intellectual Property

Investor Center

bd@claritypharmaceuticals.com

SUBSCRIBE TO CLARITY’S NEWSLETTER

Sign up to receive the most recent news and updates.

© Clarity Pharmaceuticals 2022 Australia